Skip to main content

Table 1 Characteristics of patients

From: Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis

  Sixty-four patients    Ninety-one pregnancies (%)
Mean ± SD   Outcome of pregnancy normal birth 73 (80.2)
 Age at diagnosis (years) 23.95±5.56   premature birth 2 (2.2)
 Disease duration (years) 7.22±6.21   spontaneous abortion 8 (8.8)
 Age at pregnancy (years) 32.25±4.36   therapeutic termination 8 (8.8)
Extent of UC n (%)   Receiving treatment for UC   
 Total colitis 30 (46.9) at the onset of pregnancy total (n=80) 50 (62.5)
 Left-side colitis 22 (34.4)   salazosulfapyridine (SASP) 20 (40)
 Proctitis 12 (18.7)   5-aminosalicylic acid  
Clinical course n (%)    compound (5-ASA) 19 (38)
 Relapsing-remitting type 53 (82.8)   SASP+prednisolone (PSL) 5 (10)
 Cronic continuous type 6 (9.4)   5-ASA+PSL 3 (6)
 Acute fulminating type 1 (1.6)   5-ASA+azathioprine 1 (2)
 First attack type 4 (6.2)   PSL 2 (4)